Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

30. Oktober 2025 08:23 ET | Quelle: The Ritedose Corporation

Ritedose Now Offers the Largest Nebulized Drug Portfolio in the U.S.: FDA Approves the Company to Manufacture Generic Tobramycin Inhalation Solution

With the addition of Tobramycin Inhalation Solution, Ritedose now provides the largest nebulized drug portfolio in the country.
24. September 2025 08:24 ET | Quelle: The Ritedose Corporation

Leading CDMO Enhances cGMP Lab Infrastructure to Strengthen Position

$17+ million investment in expanded microbiology lab and analytical chemistry capabilities positions Ritedose for accelerated growth.
18. Januar 2022 10:00 ET | Quelle: The RiteDose Corporation

The Ritedose Corporation Announces Revolutionary Liquid Med Dispenser

COLUMBIA, S.C., Jan. 18, 2022 (GLOBE NEWSWIRE) -- The Ritedose Corporation has announced the development of and plans to commercialize the first new way to dispense single-dose liquid medications in...
03. August 2021 07:03 ET | Quelle: The RiteDose Corporation

RiteDose Efficiency Innovation Yields Up to 25% Increase in CDMO Production Capability

Columbia, SC, Aug. 03, 2021 (GLOBE NEWSWIRE) -- The RiteDose Corporation, the company born from the inventors of Blow-Fill-Seal (BFS) technology, has implemented engineering innovations that will...